These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy. Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980 [TBL] [Abstract][Full Text] [Related]
5. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. Palmer BE; Boritz E; Wilson CC J Immunol; 2004 Mar; 172(5):3337-47. PubMed ID: 14978142 [TBL] [Abstract][Full Text] [Related]
6. HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells. Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM AIDS; 1999 Aug; 13(12):1583-4. PubMed ID: 10465085 [No Abstract] [Full Text] [Related]
7. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication. Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131 [TBL] [Abstract][Full Text] [Related]
8. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals. Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229 [TBL] [Abstract][Full Text] [Related]
9. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production. Tomiyama H; Akari H; Adachi A; Takiguchi M J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566 [TBL] [Abstract][Full Text] [Related]
10. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657 [TBL] [Abstract][Full Text] [Related]
11. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Rosenberg ES; Billingsley JM; Caliendo AM; Boswell SL; Sax PE; Kalams SA; Walker BD Science; 1997 Nov; 278(5342):1447-50. PubMed ID: 9367954 [TBL] [Abstract][Full Text] [Related]
12. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093 [TBL] [Abstract][Full Text] [Related]
13. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751 [TBL] [Abstract][Full Text] [Related]
14. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. Paliard X; Liu Y; Wagner R; Wolf H; Baenziger J; Walker CM AIDS Res Hum Retroviruses; 2000 Feb; 16(3):273-82. PubMed ID: 10710215 [TBL] [Abstract][Full Text] [Related]
15. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes. Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children. Scott ZA; Beaumier CM; Sharkey M; Stevenson M; Luzuriaga K J Immunol; 2003 Jun; 170(11):5786-92. PubMed ID: 12759463 [TBL] [Abstract][Full Text] [Related]
17. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses. Ostrowski MA; Justement SJ; Ehler L; Mizell SB; Lui S; Mican J; Walker BD; Thomas EK; Seder R; Fauci AS J Immunol; 2000 Dec; 165(11):6133-41. PubMed ID: 11086046 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Carmichael A; Jin X; Sissons P; Borysiewicz L J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890 [TBL] [Abstract][Full Text] [Related]
19. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442 [TBL] [Abstract][Full Text] [Related]
20. HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity. Vingert B; Perez-Patrigeon S; Jeannin P; Lambotte O; Boufassa F; Lemaître F; Kwok WW; Theodorou I; Delfraissy JF; Thèze J; Chakrabarti LA; PLoS Pathog; 2010 Feb; 6(2):e1000780. PubMed ID: 20195518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]